| pubmed-article:233688 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:233688 | lifeskim:mentions | umls-concept:C0086418 | lld:lifeskim |
| pubmed-article:233688 | lifeskim:mentions | umls-concept:C0549473 | lld:lifeskim |
| pubmed-article:233688 | lifeskim:mentions | umls-concept:C0332441 | lld:lifeskim |
| pubmed-article:233688 | lifeskim:mentions | umls-concept:C0040160 | lld:lifeskim |
| pubmed-article:233688 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
| pubmed-article:233688 | lifeskim:mentions | umls-concept:C0205117 | lld:lifeskim |
| pubmed-article:233688 | pubmed:issue | 5 | lld:pubmed |
| pubmed-article:233688 | pubmed:dateCreated | 1983-6-17 | lld:pubmed |
| pubmed-article:233688 | pubmed:abstractText | Effects of TSH on the adenylate cyclase-cAMP system and some parameters of intermediary metabolism were investigated in human thyroid carcinoma and adjacent normal thyroid tissue. Basal adenylate cyclase activity and cAMP concentrations were significantly higher in carcinomatous tissue. Basal [1-14C]glucose oxidation, 32Pi incorporation into phospholipids, and organification of iodide were similar in both tissues. Stimulation of cAMP by TSH was significantly greater in normal compared to carcinomatous tissue. In neither tissue was there a good correlation between TSH stimulation of adenylate cyclase activity and cAMP concentrations. The TSH stimulation of 32Pi incorporation into phospholipids by TSH was significantly greater in normal tissue. The mean effect of TSH on iodide organification and glucose oxidation was similar in normal and carcinomatous tissue. Although specific binding of TSH was demonstrated in both normal and carcinomatous tissue, it did not correlate very well with stimulation of adenylate cyclase activity. Hormones other than TSH also augmented adenylate cyclase activity in two of the carcinomas. In individual patients, the relative responsivity of carcinomatous tissue compared to normal was not always consistent when all of the metabolic parameters were considered. | lld:pubmed |
| pubmed-article:233688 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:233688 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:233688 | pubmed:language | eng | lld:pubmed |
| pubmed-article:233688 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:233688 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:233688 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:233688 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:233688 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:233688 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:233688 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:233688 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:233688 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:233688 | pubmed:month | Nov | lld:pubmed |
| pubmed-article:233688 | pubmed:issn | 0021-972X | lld:pubmed |
| pubmed-article:233688 | pubmed:author | pubmed-author:KotaniMM | lld:pubmed |
| pubmed-article:233688 | pubmed:author | pubmed-author:LarsenP RPR | lld:pubmed |
| pubmed-article:233688 | pubmed:author | pubmed-author:DekkerAA | lld:pubmed |
| pubmed-article:233688 | pubmed:author | pubmed-author:FieldJ BJB | lld:pubmed |
| pubmed-article:233688 | pubmed:author | pubmed-author:BloomGG | lld:pubmed |
| pubmed-article:233688 | pubmed:author | pubmed-author:KerinsM EME | lld:pubmed |
| pubmed-article:233688 | pubmed:author | pubmed-author:KariyaTT | lld:pubmed |
| pubmed-article:233688 | pubmed:author | pubmed-author:ChouM CMC | lld:pubmed |
| pubmed-article:233688 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:233688 | pubmed:volume | 47 | lld:pubmed |
| pubmed-article:233688 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:233688 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:233688 | pubmed:pagination | 1052-8 | lld:pubmed |
| pubmed-article:233688 | pubmed:dateRevised | 2007-11-14 | lld:pubmed |
| pubmed-article:233688 | pubmed:meshHeading | pubmed-meshheading:233688-H... | lld:pubmed |
| pubmed-article:233688 | pubmed:meshHeading | pubmed-meshheading:233688-T... | lld:pubmed |
| pubmed-article:233688 | pubmed:meshHeading | pubmed-meshheading:233688-T... | lld:pubmed |
| pubmed-article:233688 | pubmed:meshHeading | pubmed-meshheading:233688-T... | lld:pubmed |
| pubmed-article:233688 | pubmed:meshHeading | pubmed-meshheading:233688-P... | lld:pubmed |
| pubmed-article:233688 | pubmed:meshHeading | pubmed-meshheading:233688-C... | lld:pubmed |
| pubmed-article:233688 | pubmed:meshHeading | pubmed-meshheading:233688-I... | lld:pubmed |
| pubmed-article:233688 | pubmed:meshHeading | pubmed-meshheading:233688-P... | lld:pubmed |
| pubmed-article:233688 | pubmed:meshHeading | pubmed-meshheading:233688-C... | lld:pubmed |
| pubmed-article:233688 | pubmed:meshHeading | pubmed-meshheading:233688-A... | lld:pubmed |
| pubmed-article:233688 | pubmed:year | 1978 | lld:pubmed |
| pubmed-article:233688 | pubmed:articleTitle | Effects of thyroid-stimulating hormone on human thyroid carcinoma and adjacent normal tissue. | lld:pubmed |
| pubmed-article:233688 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:233688 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:233688 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:233688 | lld:pubmed |
